The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $15.74 in the prior trading day, Sotera Health Co (NASDAQ: SHC) closed at $16.13, up 2.48%. In other words, the price has increased by $2.48 from its previous closing price. On the day, 11.38 million shares were traded. SHC stock price reached its highest trading level at $16.235 during the session, while it also had its lowest trading level at $15.785.
Ratios:
Our goal is to gain a better understanding of SHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 39.93. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 4.14 whereas as Long-Term Debt/Eq ratio is at 4.10.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.
On May 21, 2024, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $13.Piper Sandler initiated its Neutral rating on May 21, 2024, with a $13 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 05 ’25 when WARBURG PINCUS & CO. sold 12,000,000 shares for $15.11 per share. The transaction valued at 181,332,000 led to the insider holds 61,822,952 shares of the business.
WARBURG PINCUS & CO. sold 12,000,000 shares of SHC for $181,332,000 on Sep 05 ’25. The Director now owns 61,822,952 shares after completing the transaction at $15.11 per share. On Sep 05 ’25, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 8,000,000 shares for $15.11 each. As a result, the insider received 120,888,000 and left with 41,215,301 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4582434816 and an Enterprise Value of 6562532864. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 83.58, and their Forward P/E ratio for the next fiscal year is 17.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.98 while its Price-to-Book (P/B) ratio in mrq is 8.32. Its current Enterprise Value per Revenue stands at 5.705 whereas that against EBITDA is 12.053.
Stock Price History:
The Beta on a monthly basis for SHC is 1.83, which has changed by 0.027415156 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.78, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is 0.23%, while the 200-Day Moving Average is calculated to be 20.79%.
Shares Statistics:
The stock has traded on average 2.00M shares per day over the past 3-months and 2654170 shares per day over the last 10 days, according to various share statistics. A total of 284.09M shares are outstanding, with a floating share count of 173.44M. Insiders hold about 38.95% of the company’s shares, while institutions hold 54.70% stake in the company. Shares short for SHC as of 1761868800 were 7150268 with a Short Ratio of 3.63, compared to 1759190400 on 7291907. Therefore, it implies a Short% of Shares Outstanding of 7150268 and a Short% of Float of 4.63.
Earnings Estimates
As of right now, 7.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.17, with high estimates of $0.18 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.84 and $0.83 for the fiscal current year, implying an average EPS of $0.84. EPS for the following year is $0.94, with 7.0 analysts recommending between $0.97 and $0.92.
Revenue Estimates
6 analysts predict $299.06M in revenue for. The current quarter. It ranges from a high estimate of $299.9M to a low estimate of $298M. As of. The current estimate, Sotera Health Co’s year-ago sales were $290.2MFor the next quarter, 6 analysts are estimating revenue of $269.74M. There is a high estimate of $277.17M for the next quarter, whereas the lowest estimate is $262.36M.
A total of 6 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.16B, resulting in an average revenue estimate of $1.16B. In the same quarter a year ago, actual revenue was $1.1BBased on 6 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.21B.
